Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines

E-ISSN： 1873-5576|14|9|832-849

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.14, Iss.9, 2014-11, pp. : 832-849

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma

By Hou Ya-Chin Chao Ying-Jui Tung Hui-Ling Wang Hao-Chen Shan Yan-Shen

Cancer, Vol. 120, Iss. 17, 2014-09 ,pp. : 2766-2777

Blackwell Publishing

Access to resources Recommend Favorite

Stem Cells, Cancer, Liver, and Liver Cancer Stem Cells: Finding a Way Out of the Labyrinth...

Current Cancer Drug Targets, Vol. 7, Iss. 6, 2007-09 ,pp. : 582-590

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review

Current Cancer Drug Targets, Vol. 14, Iss. 7, 2014-09 ,pp. : 610-620

Bentham Science Publishers

Access to resources Recommend Favorite

Role of α7-Nicotinic Acetylcholine Receptor in Normal and Cancer Stem Cells

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 356-365

Bentham Science Publishers

Access to resources Recommend Favorite

Stem Cells: Their Role in Breast Cancer Development and Resistance to Treatment

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 2, 2011-02 ,pp. : 196-205

Bentham Science Publishers

Access to resources Recommend Favorite